No abstract available
Publication types
-
Clinical Trial
-
Comparative Study
MeSH terms
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / therapeutic use
-
Body Temperature
-
Drug Administration Schedule
-
Female
-
Filgrastim
-
Granulocyte Colony-Stimulating Factor / adverse effects
-
Granulocyte Colony-Stimulating Factor / chemistry
-
Granulocyte Colony-Stimulating Factor / therapeutic use*
-
Granulocyte-Macrophage Colony-Stimulating Factor / adverse effects
-
Granulocyte-Macrophage Colony-Stimulating Factor / chemistry
-
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
-
Humans
-
Injections, Subcutaneous
-
Inpatients
-
Male
-
Middle Aged
-
Neoplasms / diagnosis
-
Neoplasms / drug therapy
-
Neoplasms / epidemiology
-
Neutropenia / chemically induced*
-
Neutropenia / diagnosis
-
Neutropenia / drug therapy*
-
Prospective Studies
-
Randomized Controlled Trials as Topic
-
Recombinant Proteins
-
Therapeutic Equivalency
-
Treatment Failure
Substances
-
Antineoplastic Agents
-
Recombinant Proteins
-
Granulocyte Colony-Stimulating Factor
-
sargramostim
-
Granulocyte-Macrophage Colony-Stimulating Factor
-
Filgrastim